Pharmacokinetic parameters analyzed from mr contrast enhancement kinetics of multiple malignant and benign breast lesions detected in the same patients.
about
Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer.Combined diffuse optical tomography (DOT) and MRI system for cancer imaging in small animals.Fundamentals of tracer kinetics for dynamic contrast-enhanced MRI.Fibrocystic change of the breast presenting as a focal lesion mimicking breast cancer in MR imagingMagnetic resonance imaging features of fibrocystic change of the breast.Angiogenesis in the progression of breast ductal proliferations.MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy.The influence of field strength and different clinical breast MRI protocols on the outcome of texture analysis using foam phantoms.Correlation between Choline Peak at MR Spectroscopy and Calcium-Sensing Receptor Expression Level in Breast Cancer: A Preliminary Clinical Study.Diagnostic value of breast proton magnetic resonance spectroscopy at 1.5T in different histopathological types
P2860
Q31138977-36D79155-99AE-4FE4-91F0-5883324B2BCBQ33251691-7DEBFFF7-7360-4C4A-99F1-B59B7CC75591Q34040125-6A56A9DA-015D-427A-9436-88858A99BAB3Q37002676-087D77D7-841F-4B63-84C2-88FFADD9CAF3Q37035348-44DAA53C-BA43-45AB-A2AF-9FA8F0D0D29BQ37166801-08EA9170-D949-4D00-B58A-63BD379DCCF4Q46125076-A7F6A545-4C12-4C06-B088-8547F326F721Q48858709-0C5EADDD-F798-41FB-8704-3B944661D858Q53637513-85676BD1-6C0C-4E1A-9536-99B3EE8608A9Q58914800-8912F5BA-D375-4E80-81D0-B194958D83C8
P2860
Pharmacokinetic parameters analyzed from mr contrast enhancement kinetics of multiple malignant and benign breast lesions detected in the same patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Pharmacokinetic parameters ana ...... detected in the same patients.
@en
Pharmacokinetic parameters ana ...... detected in the same patients.
@nl
type
label
Pharmacokinetic parameters ana ...... detected in the same patients.
@en
Pharmacokinetic parameters ana ...... detected in the same patients.
@nl
prefLabel
Pharmacokinetic parameters ana ...... detected in the same patients.
@en
Pharmacokinetic parameters ana ...... detected in the same patients.
@nl
P2093
P2860
P1476
Pharmacokinetic parameters ana ...... detected in the same patients.
@en
P2093
Christine E McLaren
Orhan Nalcioglu
Phillip M Carpenter
P2860
P304
P356
10.1177/153303460500400305
P577
2005-06-01T00:00:00Z